HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
FLNA holding history
Filana Therapeutics, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FLNA overviewAll 13F holders of FLNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 50
- Value
- $60
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 50 | $60 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 50 | $85 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 50 | $99 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 50 | $146 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 50 | $91 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 50 | $75 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 50 | $118 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 50 | $1.47K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 50 | $618 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 50 | $1.01K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 50 | $1.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 50 | $832 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 50 | $1.23K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 50 | $1.21K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 50 | $1.48K | <0.1% | −46−47.9% | Reduced | Holders |
| Q3 2022 | 96 | $4.00K | <0.1% | +25+35.2% | Added | Holders |
| Q2 2022 | 71 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 71 | $3.00K | <0.1% | +6+9.2% | Added | Holders |
| Q4 2021 | 65 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 65 | $4.00K | <0.1% | +20+44.4% | Added | Holders |
| Q2 2021 | 45 | $4.00K | <0.1% | +27+150.0% | Added | Holders |
| Q1 2021 | 18 | $1.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.